skip to primary navigationskip to content

Cambridge Service Alliance

At the forefront of service transformation in the digital era

Studying at Cambridge

 

Ecosystems Evolution Enabled by Technology

Ecosystem evolution enabled by technology – an example in Healthcare

Healthcare is changing – fast

The search for new business models for the Pharmaceutical industry is being driven by a number of factors:

  1. Society’s healthcare burden is growing due to populations that are living longer (and being unwell for longer)
  2. Payors want to now pay for outcomes from medicines not just for the pills
  3. Generics (launched after patent expiry) are cutting the value of established brands and markets
  4. Pharma R&D is not producing the blockbusters companies have needed to support their revenues
  5. Pharmaceutical companies are looking to switch roles from being pure manufacturers to service providers delivering outcomes

 

Is personalised medicine finally here?

IBM’s Smarter Planet concept – that increasing instrumentation and interconnections are making the world more intelligent – shows that by connecting healthcare devices such as pill dispensers, and health monitoring devices (e.g. glucose meters, etc), insight can be gained to health at the individual, and population scale.

Such insight would benefit multiple stakeholders in the healthcare ecosystem:

Patients quantify their health outcomes, and Carers receive support through reminders. 
Healthcare providers gain insight to patient health, from which to recommend appropriate interventions.  Payors benefit from lower healthcare costs and focus on patient outcomes

New players are going to change the health ecosystem

The large-scale, long-term deployment of this approach, based on an extensive collaboration between healthcare and technology could deliver:

  1. Novel analytical techniques enabling patients, HCPs, and other stakeholders to act quickly 
  2. Accelerated incorporation of analytics using advanced, predictive capabilities for pattern and context recognition into health assessment
  3. Value-based pricing for medicines based on pseudo real-time health outcomes data that will radically alter the way in which medicines are developed and priced by the pharmaceutical industry.

Contact: Amer Fasihi

Filed under: , ,

RSS Feed Latest news

A machine learning approach to quality control

Nov 14, 2020

Most of the products we take for granted contain huge numbers of components assembled in multiple stages by different manufacturers. Quality control is vital throughout the assembly process with rigorous testing required at every step.

Digital twins: driving business model innovation

Nov 06, 2020

For B2B firms struggling to reap the rewards of digitalisation, could digital twins be the way forward? In this article, CSA's Dr Erika Pärn and colleagues from the Fraunhofer Institute and Technische Universität in Dortmund, explore the relationship between this emerging technology and business model innovation.

Making business model innovation happen: the Business Model Cohesiveness Scorecard

Oct 30, 2020

Digital transformation is failing to live up to its hype, at least as far as productivity gains are concerned. If, as research suggests, a lack of business model innovation is the main culprit, we need a way of making it happen. Dr Chander Velu thinks a balanced scorecard approach could be the answer.

2020 Annual Review

Oct 23, 2020

Read about our latest research in our tenth anniversary Annual Review.

Managing customer experience through a systematic approach to data analytics

Jul 24, 2020

We all know what a positive – or negative – customer experience feels like: a rush of pleasure or teeth-grinding frustration. Firms are acutely aware of the importance of how we feel – and how that translates into long-term loyalty – but feelings are a difficult and complicated thing to measure at scale.

View all news